Pharmaceutical innovation, reference pricing and therapeutic classes

This paper is a first attempt to model the effects of reference pricing on the innovation effort of pharmaceutical firms. The model is based on a dynamic game involving three types of agents: pharmaceutical firms, consumers and a regulatory entity. The games includes research stages where the innova...